Skip to main content
Erschienen in: International Journal of Hematology 6/2013

01.06.2013 | Original Article

Genotypic and phenotypic features of Japanese patients with mild to moderate hemophilia A

verfasst von: Hiroshi Inaba, Keiko Shinozawa, Ikuo Seita, Manabu Otaki, Takashi Suzuki, Takeshi Hagiwara, Kagehiro Amano, Katsuyuki Fukutake

Erschienen in: International Journal of Hematology | Ausgabe 6/2013

Einloggen, um Zugang zu erhalten

Abstract

Hemophilia A is the most common inherited bleeding disorder. To better understand the genotypic and phenotypic features of Japanese patients with mild to moderate hemophilia A, we studied 29 unrelated patients with more than 1 % FVIII activity (FVIII:C). Differences were observed in nine of 21 patients in measured FVIII:C levels between the one-stage clotting and chromogenic assays. We identified a mutation in F8 in 28 of the 29 patients. Mutations in two amino acids, Y492 and R550, were detected at a much higher frequency in our patients than in the international hemophilia A mutation database. We demonstrated that all five patients with the Y492C mutation have an identical F8 haplotype that is unique to them, suggesting that the mutation may have originated from a common ancestor. Because non-severe, moderate to mild, hemophilia patients have a longer lifespan, mutations that cause non-severe phenotypes tend to persist in the population. We believe that the Y492C mutation is a distinctive feature of Japanese patients with mild hemophilia A. The identification of a high frequency of R550 mutation that underlies the discrepancies in FVIII:C measurements in the present study suggests that Japanese patients with mild hemophilia may require careful characterization.
Literatur
1.
Zurück zum Zitat White GC, Rosendaal F, Aledort LM, Lusher JM, Rothschild C, Ingerslev J, et al. Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost. 2001;85:560.PubMed White GC, Rosendaal F, Aledort LM, Lusher JM, Rothschild C, Ingerslev J, et al. Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost. 2001;85:560.PubMed
2.
Zurück zum Zitat Antonarakis SE, Kazazian HH, Tuddenham EG. Molecular etiology of factor VIII deficiency in hemophilia A. Hum Mutat. 1995;5:1–22.PubMedCrossRef Antonarakis SE, Kazazian HH, Tuddenham EG. Molecular etiology of factor VIII deficiency in hemophilia A. Hum Mutat. 1995;5:1–22.PubMedCrossRef
3.
Zurück zum Zitat Toole JJ, Knopf JL, Wozney JM, Sultzman LA, Buecker JL, Pittman DD, et al. Molecular cloning of a cDNA encoding human antihaemophilic factor. Nature. 1984;312:342–7.PubMedCrossRef Toole JJ, Knopf JL, Wozney JM, Sultzman LA, Buecker JL, Pittman DD, et al. Molecular cloning of a cDNA encoding human antihaemophilic factor. Nature. 1984;312:342–7.PubMedCrossRef
4.
Zurück zum Zitat Gitschier J, Wood WI, Goralka TM, Wion KL, Chen EY, Eaton DH, et al. Characterization of the human factor VIII gene. Nature. 1984;312:326–30.PubMedCrossRef Gitschier J, Wood WI, Goralka TM, Wion KL, Chen EY, Eaton DH, et al. Characterization of the human factor VIII gene. Nature. 1984;312:326–30.PubMedCrossRef
5.
Zurück zum Zitat Wood WI, Capon DJ, Simonsen CC, Eaton DL, Gitschier J, Keyt B, et al. Expression of active human factor VIII from recombinant DNA clones. Nature. 1984;312:330–7.PubMedCrossRef Wood WI, Capon DJ, Simonsen CC, Eaton DL, Gitschier J, Keyt B, et al. Expression of active human factor VIII from recombinant DNA clones. Nature. 1984;312:330–7.PubMedCrossRef
6.
Zurück zum Zitat Vehar GA, Keyt B, Eaton D, Rodriguez H, O’Brien DP, Rotblat F, et al. Structure of human factor VIII. Nature. 1984;312:337–42.PubMedCrossRef Vehar GA, Keyt B, Eaton D, Rodriguez H, O’Brien DP, Rotblat F, et al. Structure of human factor VIII. Nature. 1984;312:337–42.PubMedCrossRef
7.
Zurück zum Zitat Inaba H, Shibata H, Yoshida S, Hagiwara T, Hanabusa H, Nagao T, et al. Inversion in Japanese patients with hemophilia A. Thromb Haemost. 1995;74:810.PubMed Inaba H, Shibata H, Yoshida S, Hagiwara T, Hanabusa H, Nagao T, et al. Inversion in Japanese patients with hemophilia A. Thromb Haemost. 1995;74:810.PubMed
8.
Zurück zum Zitat Santacroce R, Santoro R, Sessa F, Iannaccaro P, Sarno M, Longo V, et al. Screening of mutations of hemophilia A in 40 Italian patients: a novel G-to-A mutation in intron 10 of the F8 gene as a putative cause of mild hemophilia A in southern Italy. Blood Coagul Fibrinolysis. 2008;19:197–202.PubMedCrossRef Santacroce R, Santoro R, Sessa F, Iannaccaro P, Sarno M, Longo V, et al. Screening of mutations of hemophilia A in 40 Italian patients: a novel G-to-A mutation in intron 10 of the F8 gene as a putative cause of mild hemophilia A in southern Italy. Blood Coagul Fibrinolysis. 2008;19:197–202.PubMedCrossRef
9.
Zurück zum Zitat Winter PC, Egan H, McNulty O, Jones FG, O’Donnell J, Jenkins PV. A recurrent F8 mutation in Irish haemophilia A patients: evidence for a founder effect. Haemophilia. 2008;14:394–5.PubMedCrossRef Winter PC, Egan H, McNulty O, Jones FG, O’Donnell J, Jenkins PV. A recurrent F8 mutation in Irish haemophilia A patients: evidence for a founder effect. Haemophilia. 2008;14:394–5.PubMedCrossRef
10.
Zurück zum Zitat Xie YG, Zheng H, Leggo J, Scully MF, Lillicrap D. A founder factor VIII mutation, valine 2016 to alanine, in a population with an extraordinarily high prevalence of mild hemophilia A. Thromb Haemost. 2002;87:178–9.PubMed Xie YG, Zheng H, Leggo J, Scully MF, Lillicrap D. A founder factor VIII mutation, valine 2016 to alanine, in a population with an extraordinarily high prevalence of mild hemophilia A. Thromb Haemost. 2002;87:178–9.PubMed
11.
Zurück zum Zitat Vidal F, Farssac E, Altisent C, Puig L, Gallardo D. Rapid hemophilia A molecular diagnosis by a simple DNA sequencing procedure: identification of 14 novel mutations. Thromb Haemost. 2001;85:580–3.PubMed Vidal F, Farssac E, Altisent C, Puig L, Gallardo D. Rapid hemophilia A molecular diagnosis by a simple DNA sequencing procedure: identification of 14 novel mutations. Thromb Haemost. 2001;85:580–3.PubMed
12.
Zurück zum Zitat Lalloz MR, McVey JH, Pattinson JK, Tuddenham EG. Haemophilia A diagnosis by analysis of a hypervariable dinucleotide repeat within the factor VIII gene. Lancet. 1991;338:207–11.PubMedCrossRef Lalloz MR, McVey JH, Pattinson JK, Tuddenham EG. Haemophilia A diagnosis by analysis of a hypervariable dinucleotide repeat within the factor VIII gene. Lancet. 1991;338:207–11.PubMedCrossRef
13.
Zurück zum Zitat Ngo JC, Huang M, Roth DA, Furie BC, Furie B. Crystal structure of human factor VIII: implications for the formation of the factor IXa-factor VIIIa complex. Structure. 2008;16:597–606.PubMedCrossRef Ngo JC, Huang M, Roth DA, Furie BC, Furie B. Crystal structure of human factor VIII: implications for the formation of the factor IXa-factor VIIIa complex. Structure. 2008;16:597–606.PubMedCrossRef
14.
Zurück zum Zitat Cooper DN, Krawczak M. The mutational spectrum of single base-pair substitutions causing human genetic disease: patterns and predictions. Hum Genet. 1990;85:55–74.PubMedCrossRef Cooper DN, Krawczak M. The mutational spectrum of single base-pair substitutions causing human genetic disease: patterns and predictions. Hum Genet. 1990;85:55–74.PubMedCrossRef
15.
Zurück zum Zitat Rudzki Z, Duncan EM, Casey GJ, Neumann M, Favaloro EJ, Lloyd JV. Mutations in a subgroup of patients with mild haemophilia A and a familial discrepancy between the one-stage and two-stage factor VIII:C methods. Br J Haematol. 1996;94:400–6.PubMedCrossRef Rudzki Z, Duncan EM, Casey GJ, Neumann M, Favaloro EJ, Lloyd JV. Mutations in a subgroup of patients with mild haemophilia A and a familial discrepancy between the one-stage and two-stage factor VIII:C methods. Br J Haematol. 1996;94:400–6.PubMedCrossRef
16.
Zurück zum Zitat Mazurier C, Gaucher C, Jorieux S, Parquet-Gernez A. Mutations in the FVIII gene in seven families with mild haemophilia A. Br J Haematol. 1997;96:426–7.PubMedCrossRef Mazurier C, Gaucher C, Jorieux S, Parquet-Gernez A. Mutations in the FVIII gene in seven families with mild haemophilia A. Br J Haematol. 1997;96:426–7.PubMedCrossRef
17.
Zurück zum Zitat Pipe SW, Eickhorst AN, McKinley SH, Saenko EL, Kaufman RJ. Mild hemophilia A caused by increased rate of factor VIII A2 subunit dissociation: evidence for nonproteolytic inactivation of factor VIIIa in vivo. Blood. 1999;93:176–83.PubMed Pipe SW, Eickhorst AN, McKinley SH, Saenko EL, Kaufman RJ. Mild hemophilia A caused by increased rate of factor VIII A2 subunit dissociation: evidence for nonproteolytic inactivation of factor VIIIa in vivo. Blood. 1999;93:176–83.PubMed
18.
Zurück zum Zitat Pipe SW, Saenko EL, Eickhorst AN, Kemball-Cook G, Kaufman RJ. Hemophilia A mutations associated with 1-stage/2-stage activity discrepancy disrupt protein–protein interactions within the triplicated A domains of thrombin-activated factor VIIIa. Blood. 2001;97:685–91.PubMedCrossRef Pipe SW, Saenko EL, Eickhorst AN, Kemball-Cook G, Kaufman RJ. Hemophilia A mutations associated with 1-stage/2-stage activity discrepancy disrupt protein–protein interactions within the triplicated A domains of thrombin-activated factor VIIIa. Blood. 2001;97:685–91.PubMedCrossRef
19.
Zurück zum Zitat Lollar P, Parker CG. pH-dependent denaturation of thrombin-activated porcine factor VIII. J Biol Chem. 1990;265:1688–92.PubMed Lollar P, Parker CG. pH-dependent denaturation of thrombin-activated porcine factor VIII. J Biol Chem. 1990;265:1688–92.PubMed
20.
Zurück zum Zitat Fay PJ, Smudzin TM. Characterization of the interaction between the A2 subunit and A1/A3-C1-C2 dimer in human factor VIIIa. J Biol Chem. 1992;267:13246–50.PubMed Fay PJ, Smudzin TM. Characterization of the interaction between the A2 subunit and A1/A3-C1-C2 dimer in human factor VIIIa. J Biol Chem. 1992;267:13246–50.PubMed
21.
Zurück zum Zitat Inaba H, Yatomi Y, Shinozawa K, Otaki M, Suzuki T, Amano K, et al. Analysis of discrepant assay-determined activity levels of factor VIII associated with R531H mutation. XXIst Congress of the International Society on Thrombosis Haemostasis. Genava. J Thromb Haemostas. 2007 Abstract P-M-126. Inaba H, Yatomi Y, Shinozawa K, Otaki M, Suzuki T, Amano K, et al. Analysis of discrepant assay-determined activity levels of factor VIII associated with R531H mutation. XXIst Congress of the International Society on Thrombosis Haemostasis. Genava. J Thromb Haemostas. 2007 Abstract P-M-126.
22.
Zurück zum Zitat Schwaab R, Oldenburg J, Schwaab U, Johnson DJ, Schmidt W, Olek K, et al. Characterization of mutations within the factor VIII gene of 73 unrelated mild and moderate haemophiliacs. Br J Haematol. 1995;91:458–64.PubMedCrossRef Schwaab R, Oldenburg J, Schwaab U, Johnson DJ, Schmidt W, Olek K, et al. Characterization of mutations within the factor VIII gene of 73 unrelated mild and moderate haemophiliacs. Br J Haematol. 1995;91:458–64.PubMedCrossRef
23.
Zurück zum Zitat Higuchi M, Antonarakis SE, Kasch L, Oldenburg J, Economou-Petersen E, Olek K, et al. Molecular characterization of mild-to-moderate hemophilia A: detection of the mutation in 25 of 29 patients by denaturing gradient gel electrophoresis. Proc Natl Acad Sci USA. 1991;88:8307–11.PubMedCrossRef Higuchi M, Antonarakis SE, Kasch L, Oldenburg J, Economou-Petersen E, Olek K, et al. Molecular characterization of mild-to-moderate hemophilia A: detection of the mutation in 25 of 29 patients by denaturing gradient gel electrophoresis. Proc Natl Acad Sci USA. 1991;88:8307–11.PubMedCrossRef
24.
Zurück zum Zitat Morichika S, Shima M, Kamisue S, Tanaka I, Imanaka Y, Suzuki H, et al. Factor VIII gene analysis in Japanese CRM-positive and CRM-reduced haemophilia A patients by single-strand conformation polymorphism. Br J Haematol. 1997;98:901–6.PubMedCrossRef Morichika S, Shima M, Kamisue S, Tanaka I, Imanaka Y, Suzuki H, et al. Factor VIII gene analysis in Japanese CRM-positive and CRM-reduced haemophilia A patients by single-strand conformation polymorphism. Br J Haematol. 1997;98:901–6.PubMedCrossRef
25.
Zurück zum Zitat Bogdanova N, Markoff A, Pollmann H, Nowak-Göttl U, Eisert R, Wermes C, et al. Spectrum of molecular defects and mutation detection rate in patients with severe hemophilia A. Hum Mutat. 2005;26:249–54.PubMedCrossRef Bogdanova N, Markoff A, Pollmann H, Nowak-Göttl U, Eisert R, Wermes C, et al. Spectrum of molecular defects and mutation detection rate in patients with severe hemophilia A. Hum Mutat. 2005;26:249–54.PubMedCrossRef
26.
Zurück zum Zitat Poulsen AL, Pedersen LH, Hvas AM, Poulsen LH, Thykjaer H, Ingerslev J. Assay discrepancy in mild haemophilia A: entire population study in a National Haemophilia Centre. Haemophilia. 2009;15:285–9.PubMedCrossRef Poulsen AL, Pedersen LH, Hvas AM, Poulsen LH, Thykjaer H, Ingerslev J. Assay discrepancy in mild haemophilia A: entire population study in a National Haemophilia Centre. Haemophilia. 2009;15:285–9.PubMedCrossRef
27.
Zurück zum Zitat Lucía JF, Aguilar C, Dobon M, Aznar JA, Tizano E, Borés C, et al. Discrepant factor VIII activity in a family with mild haemophilia A and 531 mutation using various FVIII assays and APTT reagents. Haemophilia. 2005;11:561–4.PubMedCrossRef Lucía JF, Aguilar C, Dobon M, Aznar JA, Tizano E, Borés C, et al. Discrepant factor VIII activity in a family with mild haemophilia A and 531 mutation using various FVIII assays and APTT reagents. Haemophilia. 2005;11:561–4.PubMedCrossRef
Metadaten
Titel
Genotypic and phenotypic features of Japanese patients with mild to moderate hemophilia A
verfasst von
Hiroshi Inaba
Keiko Shinozawa
Ikuo Seita
Manabu Otaki
Takashi Suzuki
Takeshi Hagiwara
Kagehiro Amano
Katsuyuki Fukutake
Publikationsdatum
01.06.2013
Verlag
Springer Japan
Erschienen in
International Journal of Hematology / Ausgabe 6/2013
Print ISSN: 0925-5710
Elektronische ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-013-1341-9

Weitere Artikel der Ausgabe 6/2013

International Journal of Hematology 6/2013 Zur Ausgabe

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.